A/Prof Ron Bova, ENT surgeon, St Vincent's Hospital Sydney: head and neck, thyroid, parathyroid and salivary gland surgery

A/Prof Ron Bova

Head and neck, thyroid, parathyroid and salivary gland surgery. MBBS (Hons), MS, FRACS

Associate Professor Ron Bova is an ENT and head and neck surgeon at St Vincent’s Hospital, Sydney, with a subspecialty practice in thyroid, parathyroid and salivary gland surgery. He graduated with first class honours from the University of New South Wales Faculty of Medicine, completed a Master of Surgery at UNSW, and was admitted as a Fellow of the Royal Australasian College of Surgeons in Otolaryngology, Head and Neck Surgery. He undertook post-fellowship training in head and neck oncology at Princess Alexandra Hospital, Brisbane, and in the Department of Otolaryngology, Head and Neck Surgery at the University of Vermont in the United States. His clinical interests include thyroid cancer, Graves’ disease and multinodular goitre, hyperparathyroidism including minimally invasive parathyroidectomy, parotid and submandibular gland tumours, head and neck cancer, and laser laryngeal surgery. He is a Clinical Associate Professor at the University of Notre Dame Sydney and has taught medical students and trainee surgeons for about two decades.

At St Vincent’s

Public clinics through St Vincent’s Hospital ENT outpatients; referrals through the St Vincent’s Hospital ENT page.

Private rooms

St Vincent’s Clinic, Suite 1003, 438 Victoria Street, Darlinghurst NSW 2010

Tel +61 2 8382 6090 · Fax +61 2 8382 6091

Links

Selected publications

  1. Stewart TJ, Bova R, Spigelman A et al. Concurrent melanoma and thyroid malignancy in a young woman. Is it genetic? Australas J Dermatol 2017;58(4):318-319. doi
  2. Goh RY, Bova R, Fogarty GB. Cutaneous squamous cell carcinoma metastatic to parotid – analysis of prognostic factors and treatment outcome. World J Surg Oncol 2012;10:117. doi
  3. Gordon DH, Stow NW, Yapa HM et al. Laryngeal cryptococcosis: Clinical presentation and treatment of a rare cause of hoarseness. Otolaryngol Head Neck Surg 2010;142(3 Suppl 1):S7-9. doi
  4. Cope D, Bova R. Steroids in otolaryngology. Laryngoscope 2008;118(9):1556-60. doi
  5. Kwong RA, Kalish LH, Nguyen TV et al. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Clin Cancer Res 2005;11(11):4107-16. doi
  6. Bova R, Goh R, Poulson M et al. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope 2005;115(5):864-9. doi
  7. Bova R, Saylor A, Coman WB. Parotidectomy: review of treatment and outcomes. ANZ J Surg 2004;74(7):563-8. doi
  8. Bova R, Cheung I, Coman W. Total glossectomy: is it justified? ANZ J Surg 2004;74(3):134-8. doi
  9. Kwong RA, Nguyen TV, Bova RJ et al. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Clin Cancer Res 2003;9(10 Pt 1):3705-11. PubMed
  10. Bova RJ, Quinn DI, Nankervis JS et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999;5(10):2810-9. PubMed

Full publication list: PubMed

All surgeons in the department →